• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Liver test abnormalities in asymptomatic and mild COVID-19 patients and their association with viral shedding time

    2022-11-29 06:44:46SiYiYuJiaRongXieJunJunLuoHongPengLuLeiXuJunJieWangXueQinChen
    World Journal of Hepatology 2022年11期

    Si-Yi Yu,Jia-Rong Xie,Jun-Jun Luo,Hong-Peng Lu,Lei Xu,Jun-Jie Wang,Xue-Qin Chen

    Abstract

    BACKGROUND

    Asymptomatic infections and mild symptoms are common in patients infected with the Omicron variant, and data on liver test abnormalities are rare.

    AIM

    To evaluated the clinical characteristics of asymptomatic and mild coronavirus disease 2019 (COVID-19) patients with abnormal liver test results.

    METHODS

    This retrospective study included 661 laboratory-confirmed asymptomatic and mild COVID-19 patients who were treated in two makeshift hospitals in Ningbo from April 5, 2022 to April 29, 2022. Clinical information and viral shedding time were collected, and univariate and multivariate logistic regression models were performed in statistical analyses.

    RESULTS

    Of the 661 patients, 83 (12.6%) had liver test abnormalities, and 6 (0.9%) had liver injuries. Abnormal liver tests revealed a reliable correlation with a history of liver disease (P < 0.001) and a potential correlation with male sex and obesity (P < 0.05). Elevated alanine aminotransferase was reliably associated with obesity (P < 0.05) and a history of liver disease (P < 0.001). Elevated aspartate transaminase (AST) was reliably correlated with a history of liver disease (P < 0.001), and potentially correlated with age over 30 years (P < 0.05). There was a reliable correlation between AST ≥ 2× the upper limit of normal and a longer viral shedding time, especially in mild cases.

    CONCLUSION

    Obesity and a history of liver disease are risk factors for liver test abnormalities. Being male and an older age are potential risk factors. Attention should be given to liver tests in asymptomatic and mild COVID-19 patients, which has crucial clinical significance for evaluating the viral shedding time.

    Key Words: COVID-19; Liver test abnormalities; Asymptomatic carriers; Mild cases; Viral shedding time;Risk factors

    INTRODUCTION

    Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This highly contagious disease poses a great threat to global public health. By September 2, 2022, the disease had resulted in 601189435 infections and 6475346 deaths[1]. In addition to respiratory symptoms and fever, 14%-69% of patients with COVID-19 have abnormal liver function tests, mainly manifested by elevations of hypoalbuminemia, gamma-glutamyl transferase, alanine aminotransferase (ALT) and aspartate aminotransferase (AST)[2,3]. Patients with severe diseases are more likely to develop elevated liver tests, suggesting an association between liver injury and the severity of disease[2,4]. Possible mechanisms of COVID-19-related liver injury include direct SARSCoV-2-induced cytopathic injury to hepatocytes and cholangiocytes, immune dysregulation and hypoxic liver injury, and drug-induced liver injury[5].

    The Omicron B.1.1.529 (BA.1) variant was first discovered in South Africa on November 9, 2021[6]. Omicron variants have rapidly replaced delta variants due to their strong interpersonal infectivity, which has caused a worldwide pandemic. Compared with patients infected with previous variants, those infected with the Omicron variants are younger, have fewer comorbidities, and develop lower severity and mortality, and asymptomatic infections and mild symptoms are more common[7-9]. However, no studies have systematically focused on liver abnormalities in asymptomatic carriers or mild cases. Previous studies have revealed that liver test abnormalities are associated with prolonged hospitalization time and viral shedding time in COVID-19 patients[10,11], indicating a prognostic indicator of poor outcome. At present, no studies have examined the association between liver abnormalities and viral shedding time in asymptomatic and mild COVID-19 patients.

    The epidemic prevention policies of different countries are established based on their own political, economic and health conditions, which are in line with the national circumstances and none is superior to others. This study was carried out under the policy of Chinese government, aiming to determine the clinical characteristics of liver test abnormalities in asymptomatic and mild COVID-19 patients infected with the Omicron BA2.2 variant[12] and their association with the viral shedding time. Our research provides suggestions for health policymakers and medical practitioners.

    MATERIALS AND METHODS

    Participants

    In this cross-sectional study, we recruited patients with COVID-19 who were treated in Ningbo Makeshift Hospital and Dapengshan Makeshift Hospital in Ningbo, Zhejiang from April 5, 2022 to April 29, 2022. All patients were transferred from Shanghai. The inclusion criteria were as follows: (1) Age over 14 years; (2) complete clinical information; and (3) asymptomatic carriers or mild cases of COVID-19. Asymptomatic carriers were those who had positive etiological tests of COVID-19 but with no clinical symptoms or imaging features of COVID-19. Mild cases were defined as confirmed cases with mild clinical symptoms and no pneumonia manifestation on imaging[13]. The exclusion criteria were as follows: (1) Ordinary cases whose pneumonia manifestation could be seen in imaging, or severe cases with respiratory distress[13]; and (2) patients who were transferred to designated hospitals for further diagnosis and treatment due to underlying diseases or other reasons. This study complied with the Declaration of Helsinki and was approved by the Ethics Committee of Ningbo First Hospital (No. 2022RS069).

    Measures

    The clinical information of patients, including age, sex, height, weight, symptoms, medical history (hypertension, diabetes, and liver diseases), and laboratory tests (complete blood count, liver tests, chest computed tomography (CT) scans, and nucleic acid tests for COVID-19), were retrospectively collected. Obesity was defined as a body mass index (BMI) ≥ 28 kg/m2. Symptoms included fever, fatigue (weakness and muscle soreness), respiratory symptoms (sore throat, dry throat, cough, and chest stuffiness), and gastrointestinal symptoms (nausea, anorexia, and diarrhea). The patients’ symptoms were collected from the electronic medical records, and were double-checked on the day of discharge. Liver diseases included chronic hepatitis B, alcoholic/nonalcoholic fatty liver disease (NAFLD) and other liver diseases. NAFLD was defined as hepatic steatosis detected by ultrasound or CT, excluding secondary causes and excessive alcohol consumption (> 30 g/d for males, and > 20 g/d for females). Hepatitis B was defined as positive serum hepatitis B surface antigen. Complete blood counts, liver and kidney tests, and chest CT scans were performed on the admission day, and nasal swabs for SARS-CoV-2 were tested every two days. All patients received Chinese medicine and symptomatic therapy (if necessary), but not antivirals or monoclonal antibodies.

    Real-time reverse transcription PCR was used to detect SARS-CoV-2, and primers targeting the open reading frame 1ab (ORF1ab) and nucleocapsid protein N were used for amplification and detection. The corresponding sequences for ORF1ab were 5'-CCCTGTGGGTTTTACACTTAA-3'(F), 5'-ACGATTGTGCATCAGCTGA-3' (R), and 5'-CY3-CCGTCTGCGGTATGTGGGAAAGGTTATGG-BHQ1-3' (probe), and those for N were 5'-GGGGAACTTCTCCTGCTAGAAT-3' (F), 5'-CAGACATTTTGCTCTCAAGCTG-30' (R), and 5'-FAM-TTGCTGCTGCTTGACAGATT-TAMRA-3' (probe). The methods were based on the criteria provided by the National Health Commission of the People’s Republic of China[14].

    Liver test abnormalities were defined as elevations of the following liver enzymes in serum: ALT > 50 U/L (male) or 40 U/L (female), AST > 40 U/L (male) or 35 U/L (female), and total bilirubin (TBIL) > 17.1 μmol/L. Liver injury was defined as ALT and/or AST more than 3× the upper limit of normal (ULN) and/or TBIL more than 2 × ULN[15].

    Viral shedding was defined as the cycle threshold (Ct) values of both ORF1ab and N greater than 35. The viral shedding time was defined as the duration from the first positive nucleic acid test to the first negative result (two consecutive negatives). Patients were discharged with significantly recovered respiratory symptoms and two consecutive negative nucleic acid tests.

    Statistical analysis

    Data were analyzed by IBM SPSS (version 26.0). Continuous variables were described by the means ± standard deviation (SD) or medians and interquartile range (IQR), while categorical variables were described by the frequency and percentage. For continuous variable comparison, independent sample T tests or one-way analysis of variance were used for normally distributed data, and Mann–Whitney U tests or Kruskal–Wallis tests were used for nonnormally distributed data. For categorical variable comparison, chi-square tests or Fisher's exact tests were applied. Ordinal logistic regression analyses were used to identify risk factors associated with liver test abnormalities, and multiple linear regression analyses were used to identify factors associated with the viral shedding time. P < 0.05 (two-sided) was considered statistically significant. The results of statistical ayalyses can be re-verified if any party wishes to confirm the credibility.

    RESULTS

    Study design and participant criteria

    The participant recruitment process is shown in Figure 1. In total, 429 patients in Ningbo Makeshift Hospital and 256 patients in Dapengshan Makeshift Hospital were selected according to the inclusion criteria. Excluding 17 ordinary cases and 7 patients who were transferred to designated hospitals (4 cases of pulmonary tuberculosis diagnosed with CT scan, one case of acute asthma attack, one case of acute appendicitis, and one case of persistent abdominal pain), 661 participants were included in the final sample.

    Figure 1 Inclusion flow chart.

    As shown in Table 1, the median age was 33 years (IQR 27-44 years), 331 (50.1%) were male, and the median BMI was 22.8 kg/m2(IQR 20.7-25.2). A total of 130 (19.7%) had underlying diseases, of whom 57 (8.6%) had liver diseases. 45 (6.8%) had NAFLD, 11 (1.7%) had hepatitis B, and 1 (0.2%) had both. A total of 425 (64.3%) patients developed a fever, and 619 (93.6%) patients had mild cases. Eighty-three (12.6%) patients had liver test abnormalities and 6 (0.9%) had liver injuries. The number of patients with elevations in ALT, AST and TBIL was 53 (8.0%), 61 (9.2%), and 4 (0.6%), respectively, with a majority of mild liver test abnormalities (Supplementary Table 1). Some patients reported medicines taken before admission, including traditional Chinese medicine (382, 57.8%), nonsteroidal anti-inflammatory drugs (NSAIDs) (89, 13.5%), and other medicines for cold (91, 13.8%).

    Table 1 Characteristics of 661 patients with coronavirus disease 2019 by liver tests

    Clinical features of COVID-19 patients with liver test abnormalities

    As shown by a univariate logistic regression model, liver test abnormalities were significantly associated with male sex [odds ratio (OR) 1.699, 95% confidence interval (CI) 1.061-2.721, P = 0.027], obesity (OR 2.707, 95%CI 1.384-5.291, P = 0.004) and a history of liver disease (OR 2.707, 95%CI 1.384-5.291, P = 0.004) but not with age, disease type, clinical manifestations or medication history (Figure 2). The correlated factors in the univariate model were taken as key factors. A multivariate logistic regression model for key factors indicated that liver test abnormalities were only associated with a history of liver disease (OR 8.004, 95%CI 4.319-14.835, P < 0.001). A multivariate logistic regression model for all factors showed that liver test abnormalities were significantly associated with the age of 30-49 years (compared with age 14-30 years, OR 1.970, 95%CI 1.073-3.618, P = 0.029), male sex (OR 1.728, 95%CI 1.005-2.971, P = 0.048), and a history of liver disease (OR 8.265, 95%CI 4.315-15.831, P < 0.001). Based on the above models, liver test abnormalities had a reliable correlation with a history of liver disease, and a potential correlation with male sex and obesity.

    As revealed by all three models in Supplementary Figure 1, elevated ALT had a firm correlation with obesity (univariate logistic regression: OR 3.82, 95%CI 1.84-7.94, P < 0.001; multivariate logistic regression for key factors: OR 2.57, 95%CI 1.15-5.70, P = 0.021; multivariate logistic regression for all factors: OR 3.31, 95%CI 1.37-7.98, P = 0.009) and a history of liver disease (univariate logistic regression: OR 9.54, 95%CI 5.01-18.16, P < 0.001; multivariate logistic regression for key factors: OR 8.30, 95%CI 4.21-16.36, P < 0.001; multivariate logistic regression for all factors: OR 9.05, 95%CI 4.31-19.01, P < 0.001). Therefore, ALT elevation was reliably correlated with obesity and a history of liver disease.

    A univariate logistic regression model indicated that elevated AST was associated with a history of liver disease (OR 8.18, 95%CI 4.40-15.24, P < 0.001, Supplementary Figure 2). A multivariate logistic regression model on all factors showed that AST elevation was associated with older age (age of 30-49 years vs age of 14-29 years: OR 2.48, 95%CI 1.18-5.20, P = 0.016; age over 50 years vs. age of 14-29 years: OR 2.81, 95%CI 1.14-6.97, P = 0.025) and a history of liver disease (OR 7.84, 95%CI 3.89-15.78, P < 0.001) (Supplementary Figure 2). Therefore, the AST elevation had a reliable correlation with a history of liver disease, and a potential correlation with age over 30 years.

    In summary, obesity and a history of liver disease were risk factors for abnormal liver test results, and male sex and age over 30 years were potential risk factors. These findings are of great clinical significance for evaluating high-risk subjects with liver abnormalities among asymptomatic and mild COVID-19 patients.

    Association between viral shedding time and liver test abnormalities

    The association between the viral shedding time and abnormal liver test results was analyzed in 657 participants after excluding 4 subjects with missing data. As shown in Table 2, the viral shedding time of patients with AST ≥ 2 × ULN were significantly prolonged (< 2 × ULN vs ≥ 2 × ULN, viral shedding time: 10.51 ± 2.76 d vs 12.40 ± 3.57 d, P = 0.033). As suggested by three models in Figure 3, AST ≥ 2 × ULN had a reliable correlation with the viral shedding time (univariate linear regression: coefficient 1.893, 95%CI 0.158-3.628, P = 0.033; multivariate linear regression of key factors: coefficient 1.862, 95%CI 0.140-3.584, P = 0.034; multivariate linear regression for all factors: coefficient 2.778, 95%CI 0.615-4.942, P= 0.012). In contrast, there was no significant correlation between ALT elevation and the viral shedding time. In addition, mild cases or female sex were associated with a longer viral shedding time (Table 2, Figure 3).

    Figure 2 Logistic regression models on factors associated with liver tests. A: Univariate logistic regression model; B: Multivariate logistic regression model on key factors; C: Multivariate logistic regression model on all factors; age: vs age 14-29 years; GI: Gastrointestinal; NSAIDs: Nonsteroidal anti-inflammatory drugs; OR: Odds ratio; CI: Confidence interval.

    Figure 3 Linear regression models on factors associated with viral shedding time. A: Univariate logistic regression model; B: Multivariate logistic regression model on key factors; C: Multivariate logistic regression model on all factors; age: vs age 14-29 years; ULN: Upper limit of normal; Coef.: Coefficient; CI:Confidence interval.

    Table 2 Comparison of viral shedding time by liver tests and other characteristics

    The correlations between the AST elevation or disease types and the viral shedding time were further analyzed. As shown in Supplementary Table 2, the viral shedding time of mild cases with AST ≥ 2 × ULN was significantly prolonged (AST ≥ 2 × ULN & mild cases vs AST < 2 × ULN & mild cases vs AST < 2 × ULN & asymptomatic carriers: 12.40 ± 3.57 d vs 10.59 ± 2.71 d vs 9.26 ± 3.16 d, P = 0.001). Therefore, it is suggested that great attention should be given to the liver test results of asymptomatic and mild COVID-19 patients, which has crucial clinical significance for predicting the viral shedding time.

    DISCUSSION

    To the best of our knowledge, this is the first clinical study focusing on liver test abnormalities in asymptomatic and mild COVID-19 patients. In the current epidemic of the Omicron BA2.2 variant, 12.6% of COVID-19 patients developed liver test abnormalities, and 0.9% developed liver injuries. The majority of the liver test abnormalities were mild. The ratio of abnormal liver tests in our study was lower than previous data of 14%-69%[2,3]. One possible reason for this was that our participants were all asymptomatic carriers or mild cases, among whom abnormal liver test results were uncommon. Previous studies revealed normal ALT and AST levels in asymptomatic patients, which were significantly lower than those with symptomatic infection[16]. In contrast, our study showed no differences in liver tests between asymptomatic carriers and mild cases. The probable reason was that all of the symptomatic patients in our study were mild cases, which weakened the difference between the two groups.

    As shown in our study, the risk factors for liver test abnormalities in asymptomatic and mild COVID-19 patients included obesity and a history of liver disease, and the potential risk factors included male sex and age over 30 years. Previous studies suggested that preexisting chronic liver diseases, such as NAFLD, chronic hepatitis B, and alcoholic liver disease, were high-risk factors for liver injury in COVID-19[17-19]. Consistent with these findings, our study verified a strong correlation between abnormal liver test results and a history of liver disease. Virus-induced cytokine storms, impaired mitochondrial activity, or endoplasmic reticulum stress may aggravate the preexisting liver disease, which further leads to the progression of liver injury[20]. In addition, liver test abnormalities were more common in males, which was similar to a previous study[21]. The higher estrogen level in females may play a protective role[22]. In addition, elevated ALT was strongly associated with obesity. This may be due to a high ratio of NAFLD patients among obese individuals, and fatty liver diseases can result in elevated ALT levels[18]. There was a potential correlation between elevated AST and age over 30 years. Since AST is known to reflect the injury of organs, such as myocardium and skeletal muscle, these organic injuries may occur more frequently in elderly patients with COVID-19.

    Medications for COVID-19 treatment, such as antibiotics and antiviral medications (e.g., lopinavir/ritonavir) have been reported to cause liver injury[10]. This study focused on the liver test features of COVID-19 patients in the early stage of the disease. These patients had rarely taken antibiotics or antiviral medications, while some had taken Chinese medicine, NSAIDs or other cold medicines for a short period. Importantly, no association was found between these medications and liver test abnormalities in COVID-19 patients.

    As reported in hospitalized COVID-19 patients, abnormal liver test results at admission were associated with a prolonged hospitalization time and viral shedding time[10,11]. Early elevation of AST was closely related to mortality, suggesting that it might be a predictor of poor prognosis for COVID-19[23]. Similarly, we also found a reliable association between the increase in AST and a prolonged viral shedding time in asymptomatic and mild COVID-19 patients. We speculate that the lower immunity of patients with elevated AST levels might affect the viral clearance. The viral shedding time was even longer in mild cases with elevated AST. Similar results have been previously revealed in which the viral shedding duration was longer in symptomatic patients than in asymptomatic patients[16,24]. Lymphocyte-mediated immune responses may play a vital role[15].

    Our study has two advantages. First, unlike studies concerning severe cases[2,4,15,23], we focused on the association between liver test results and viral shedding time, especially in patients infected with the Omicron BA2.2 variant, with a relatively high proportion of asymptomatic carriers and mild cases. The viral shedding time for patients with elevated AST were significantly longer, especially in mild patients. This provides crucial evidence for identifying high-risk patients with a prolonged viral shedding time. Second, we analyzed the risk factors for liver test abnormalities. Male sex, older age, obesity, and a history of liver disease may increase the risk of liver abnormalities, which can be used to identify high-risk patients with abnormal liver test results.

    One limitation of our research is that we only measured the levels of ALT, AST, and TBIL, but failed to obtain other liver test results, such as γ-glutamyl transpeptidase and alkaline phosphatase, and we did not monitor the dynamic alterations of the liver tests. The absence of these indicators may have led to an incomplete assessment of liver abnormalities. Another limitation is that we only recruited participants from two makeshift hospitals in Ningbo, but not from multiple regions. This may have led to a limited sample size and underrepresentation of the sample.

    CONCLUSION

    We evaluated the liver test features of asymptomatic and mild COVID-19 patients during the epidemic of the Omicron BA2.2 variant. Patients with a history of liver disease or male patients were more likely to develop liver test abnormalities or liver injury. Those who were obese or had a history of liver disease tended to develop ALT elevation, and those who were aged over 30 years or had a history of liver disease tended to develop AST elevation. The increase in AST in the early stage was closely associated with a prolonged viral shedding time, especially in mild cases. Attention should be given to the liver test data of asymptomatic and mild COVID-19 patients, which has important clinical significance for evaluating the viral shedding time.

    ARTICLE HIGHLIGHTS

    FOOTNOTES

    Author contributions: Yu SY designed the study and drafted the manuscript; Yu SY, Luo JJ, Lu HP and Wang JJ organized the data; Yu SY and Xie JR performed the statistical analyses; Chen XQ and Xu L supervised the study design and conduction.

    Supported by the Ningbo Medical Science and Technology Program, No. 2019Y32; Ningbo 2025 Science and Technology Major Project, No. 2021Z018; and Ningbo Natural Science Foundation of China, No. 2021J263.

    Institutional review board statement: This study was approved by the Ethics Committee of Ningbo First Hospital (No. 2022RS069).

    Informed consent statement: The data of our study was collected retrospectively, and the informed consent was exempted by the Ethics Committee of Ningbo First Hospital.

    Conflict-of-interest statement: All the authors declare that they have no conflict of interest.

    Data sharing statement: No additional data are available.

    Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin: China

    ORCID number: Si-Yi Yu 0000-0002-8295-1066; Jia-Rong Xie 0000-0002-1262-3411; Xue-Qin Chen 0000-0002-1828-1985.

    S-Editor: Liu JH

    L-Editor: A

    P-Editor: Liu JH

    男插女下体视频免费在线播放| 日韩欧美一区二区三区在线观看| 国产精品1区2区在线观看.| 亚洲免费av在线视频| 国产精品爽爽va在线观看网站| 精品人妻1区二区| 熟妇人妻久久中文字幕3abv| 欧洲精品卡2卡3卡4卡5卡区| 久久久国产成人免费| 精品国产乱码久久久久久男人| 精品国产美女av久久久久小说| 国产精品综合久久久久久久免费| 亚洲 欧美一区二区三区| 久久这里只有精品19| 免费看美女性在线毛片视频| 午夜a级毛片| 99久久久亚洲精品蜜臀av| 成人永久免费在线观看视频| 国产人伦9x9x在线观看| 午夜成年电影在线免费观看| 在线观看免费午夜福利视频| 久久精品影院6| 午夜福利欧美成人| 小说图片视频综合网站| 中文字幕高清在线视频| 欧美一级毛片孕妇| 国内精品久久久久久久电影| 99riav亚洲国产免费| 久久精品综合一区二区三区| 美女大奶头视频| 亚洲熟女毛片儿| 男男h啪啪无遮挡| www.精华液| 两性夫妻黄色片| 色综合站精品国产| 亚洲av成人不卡在线观看播放网| 一区二区三区国产精品乱码| 国产97色在线日韩免费| 一夜夜www| 久久精品国产亚洲av香蕉五月| 国产精品久久久久久久电影 | 国产精品99久久99久久久不卡| 久久伊人香网站| 久久性视频一级片| cao死你这个sao货| 国产三级黄色录像| 久久人人精品亚洲av| 久久国产精品影院| netflix在线观看网站| 亚洲男人的天堂狠狠| 老司机午夜十八禁免费视频| 麻豆av在线久日| 俄罗斯特黄特色一大片| 亚洲18禁久久av| 美女午夜性视频免费| 亚洲精品中文字幕在线视频| 黑人操中国人逼视频| 久久久久精品国产欧美久久久| 99在线视频只有这里精品首页| 午夜亚洲福利在线播放| 丰满人妻一区二区三区视频av | 神马国产精品三级电影在线观看 | 欧美zozozo另类| 国产精品久久久久久精品电影| 又爽又黄无遮挡网站| 久久久久久久久久黄片| 亚洲精品中文字幕在线视频| 天天一区二区日本电影三级| 免费观看精品视频网站| 久久精品国产99精品国产亚洲性色| 日本一二三区视频观看| 精品欧美国产一区二区三| www国产在线视频色| 91大片在线观看| 亚洲av片天天在线观看| 亚洲国产欧美网| 一级毛片高清免费大全| 午夜日韩欧美国产| 在线观看舔阴道视频| 欧美日韩精品网址| 欧美成人午夜精品| 人妻夜夜爽99麻豆av| 日韩成人在线观看一区二区三区| 亚洲成人中文字幕在线播放| 国产精品av视频在线免费观看| 免费av毛片视频| 国产欧美日韩精品亚洲av| 国产精品日韩av在线免费观看| 俄罗斯特黄特色一大片| 亚洲欧美日韩高清专用| 热99re8久久精品国产| 性欧美人与动物交配| 法律面前人人平等表现在哪些方面| 国产探花在线观看一区二区| 亚洲一区二区三区不卡视频| 精品福利观看| 欧美激情久久久久久爽电影| 全区人妻精品视频| 成人av一区二区三区在线看| 97碰自拍视频| 久久精品夜夜夜夜夜久久蜜豆 | 久久香蕉国产精品| 日韩欧美免费精品| 香蕉丝袜av| 国内毛片毛片毛片毛片毛片| 岛国在线免费视频观看| 国产亚洲av嫩草精品影院| 香蕉国产在线看| 99精品久久久久人妻精品| 国产视频内射| 国产成人啪精品午夜网站| 精品欧美一区二区三区在线| 一本久久中文字幕| av视频在线观看入口| 黄片小视频在线播放| 1024香蕉在线观看| 久久精品国产亚洲av香蕉五月| 久久久久久久久久黄片| 国产精品香港三级国产av潘金莲| 亚洲美女视频黄频| 男女下面进入的视频免费午夜| 国产主播在线观看一区二区| 婷婷六月久久综合丁香| 日本 av在线| 国产野战对白在线观看| 国产高清视频在线播放一区| 手机成人av网站| 日韩精品中文字幕看吧| 亚洲成av人片在线播放无| 一级毛片精品| 黄色a级毛片大全视频| 久久久久精品国产欧美久久久| 国产97色在线日韩免费| 后天国语完整版免费观看| 亚洲一卡2卡3卡4卡5卡精品中文| 黄色片一级片一级黄色片| 桃红色精品国产亚洲av| 夜夜爽天天搞| 色播亚洲综合网| 欧美日韩乱码在线| 色综合站精品国产| av视频在线观看入口| 操出白浆在线播放| 午夜精品在线福利| 麻豆成人午夜福利视频| e午夜精品久久久久久久| 蜜桃久久精品国产亚洲av| 天堂av国产一区二区熟女人妻 | 91在线观看av| 一本综合久久免费| 精品高清国产在线一区| 9191精品国产免费久久| 99国产精品一区二区三区| 亚洲熟女毛片儿| 亚洲乱码一区二区免费版| 一区福利在线观看| 国产私拍福利视频在线观看| 90打野战视频偷拍视频| 日本 欧美在线| www国产在线视频色| svipshipincom国产片| 亚洲avbb在线观看| 成人国语在线视频| 免费看日本二区| 国产成+人综合+亚洲专区| 国产精品电影一区二区三区| 亚洲av成人一区二区三| 777久久人妻少妇嫩草av网站| 成人av一区二区三区在线看| 亚洲国产精品sss在线观看| 啦啦啦免费观看视频1| 色综合亚洲欧美另类图片| 88av欧美| 午夜亚洲福利在线播放| 男人的好看免费观看在线视频 | 日韩精品中文字幕看吧| 国产一级毛片七仙女欲春2| 国产一区在线观看成人免费| 日韩三级视频一区二区三区| 视频区欧美日本亚洲| 少妇裸体淫交视频免费看高清 | 精品日产1卡2卡| 男女那种视频在线观看| 亚洲中文日韩欧美视频| 亚洲色图av天堂| 亚洲国产精品合色在线| 日本黄大片高清| 日韩欧美国产一区二区入口| 一区福利在线观看| 亚洲av电影在线进入| 两个人视频免费观看高清| 男插女下体视频免费在线播放| 久久久久性生活片| 国产又黄又爽又无遮挡在线| 中文字幕av在线有码专区| 超碰成人久久| 波多野结衣高清无吗| 国产av不卡久久| 性色av乱码一区二区三区2| 18禁黄网站禁片午夜丰满| 成人国语在线视频| 久久草成人影院| 看免费av毛片| 欧美日韩瑟瑟在线播放| 老汉色∧v一级毛片| 亚洲乱码一区二区免费版| 日韩成人在线观看一区二区三区| 亚洲片人在线观看| 国产精品九九99| 国产亚洲精品久久久久5区| av福利片在线| 欧美中文综合在线视频| netflix在线观看网站| 国产视频一区二区在线看| 久久香蕉精品热| 亚洲中文字幕日韩| 欧美三级亚洲精品| 三级国产精品欧美在线观看 | xxx96com| 国产亚洲精品av在线| 全区人妻精品视频| 婷婷精品国产亚洲av在线| 国产精品av视频在线免费观看| 久久精品aⅴ一区二区三区四区| 18禁黄网站禁片免费观看直播| 99re在线观看精品视频| 欧美黑人精品巨大| 国产精品免费一区二区三区在线| www.999成人在线观看| 18禁黄网站禁片免费观看直播| 日韩 欧美 亚洲 中文字幕| 欧美黑人精品巨大| 国产免费av片在线观看野外av| 国产精品久久久人人做人人爽| 国产私拍福利视频在线观看| 日本精品一区二区三区蜜桃| 中文字幕人妻丝袜一区二区| 亚洲精品粉嫩美女一区| 国产亚洲欧美在线一区二区| av视频在线观看入口| 国产av又大| 欧美黄色淫秽网站| 亚洲天堂国产精品一区在线| 国产精品电影一区二区三区| 99久久99久久久精品蜜桃| 女人爽到高潮嗷嗷叫在线视频| 老司机在亚洲福利影院| 在线观看免费视频日本深夜| 久久久久久免费高清国产稀缺| 免费在线观看影片大全网站| 亚洲成人久久性| 日韩精品青青久久久久久| 村上凉子中文字幕在线| ponron亚洲| 国产精品久久久久久亚洲av鲁大| 18禁黄网站禁片免费观看直播| 欧美黑人精品巨大| 99在线人妻在线中文字幕| 精品久久久久久久毛片微露脸| 国产午夜精品久久久久久| 90打野战视频偷拍视频| 国产成人精品无人区| 久久久久久久精品吃奶| 色播亚洲综合网| 99riav亚洲国产免费| 国产成人一区二区三区免费视频网站| 婷婷丁香在线五月| 观看免费一级毛片| 国产精品亚洲美女久久久| 久久人妻福利社区极品人妻图片| 久久精品综合一区二区三区| 久久亚洲真实| www.熟女人妻精品国产| 亚洲人成网站在线播放欧美日韩| 国产成人系列免费观看| 一进一出好大好爽视频| 午夜福利免费观看在线| av超薄肉色丝袜交足视频| 99热6这里只有精品| 亚洲第一电影网av| 可以在线观看毛片的网站| 日本熟妇午夜| 每晚都被弄得嗷嗷叫到高潮| 日韩 欧美 亚洲 中文字幕| 91av网站免费观看| 婷婷丁香在线五月| 手机成人av网站| 男人舔女人下体高潮全视频| 大型av网站在线播放| 欧美极品一区二区三区四区| 亚洲av五月六月丁香网| 日韩 欧美 亚洲 中文字幕| 淫秽高清视频在线观看| 狂野欧美白嫩少妇大欣赏| 在线国产一区二区在线| 免费看a级黄色片| 国产成年人精品一区二区| 一个人免费在线观看电影 | 国产精品久久久久久精品电影| 国产精品爽爽va在线观看网站| 亚洲精华国产精华精| 97超级碰碰碰精品色视频在线观看| 久久久久久久久免费视频了| 天天一区二区日本电影三级| 亚洲专区中文字幕在线| 丰满的人妻完整版| 老鸭窝网址在线观看| 精品久久久久久成人av| 国产精品乱码一区二三区的特点| 99久久久亚洲精品蜜臀av| 美女大奶头视频| 久久久久久大精品| 嫁个100分男人电影在线观看| 国产97色在线日韩免费| 看片在线看免费视频| 亚洲人成网站在线播放欧美日韩| 一级a爱片免费观看的视频| 成在线人永久免费视频| 国产av又大| 国产激情久久老熟女| 99久久99久久久精品蜜桃| 一边摸一边做爽爽视频免费| 亚洲成人久久性| 亚洲精品久久成人aⅴ小说| 国产一区二区激情短视频| 亚洲一码二码三码区别大吗| 国产精品美女特级片免费视频播放器 | 99国产精品99久久久久| 在线观看66精品国产| 在线视频色国产色| 一个人免费在线观看电影 | 久久久久久大精品| 国内毛片毛片毛片毛片毛片| 啪啪无遮挡十八禁网站| 91麻豆av在线| 亚洲av中文字字幕乱码综合| 老熟妇乱子伦视频在线观看| 亚洲全国av大片| 久久精品aⅴ一区二区三区四区| 99在线人妻在线中文字幕| 日本 欧美在线| 女警被强在线播放| 亚洲精品国产一区二区精华液| 可以在线观看毛片的网站| 天天一区二区日本电影三级| 岛国在线观看网站| 日韩免费av在线播放| 国产av一区二区精品久久| 久久久久久大精品| 久久精品成人免费网站| 国产69精品久久久久777片 | АⅤ资源中文在线天堂| 我要搜黄色片| 男人的好看免费观看在线视频 | 色老头精品视频在线观看| 国产午夜福利久久久久久| 国产野战对白在线观看| 亚洲男人天堂网一区| 欧美黑人巨大hd| 国产成人av教育| 成年女人毛片免费观看观看9| 欧美一级a爱片免费观看看 | 巨乳人妻的诱惑在线观看| 九九热线精品视视频播放| 成人午夜高清在线视频| 一进一出抽搐动态| xxx96com| 国产精品99久久99久久久不卡| 人人妻,人人澡人人爽秒播| 免费电影在线观看免费观看| 色播亚洲综合网| 又爽又黄无遮挡网站| 波多野结衣巨乳人妻| 亚洲一区二区三区色噜噜| 亚洲精品久久成人aⅴ小说| 久久久久久久午夜电影| 亚洲精品久久国产高清桃花| 亚洲精品国产一区二区精华液| 特级一级黄色大片| 久久久久亚洲av毛片大全| 在线观看66精品国产| 亚洲欧美日韩无卡精品| 亚洲成人国产一区在线观看| 亚洲无线在线观看| 久9热在线精品视频| 免费看日本二区| 男男h啪啪无遮挡| 国模一区二区三区四区视频 | 又黄又爽又免费观看的视频| 两人在一起打扑克的视频| 成人18禁高潮啪啪吃奶动态图| 欧美激情久久久久久爽电影| 在线国产一区二区在线| 国产在线观看jvid| 免费看十八禁软件| 欧美成人免费av一区二区三区| 激情在线观看视频在线高清| 此物有八面人人有两片| 久久亚洲真实| 91大片在线观看| 国产亚洲精品第一综合不卡| 丝袜美腿诱惑在线| 国产精品一区二区免费欧美| 亚洲专区中文字幕在线| 国产成人精品无人区| 欧美久久黑人一区二区| 色在线成人网| 一级作爱视频免费观看| 国产伦在线观看视频一区| 此物有八面人人有两片| 最近最新中文字幕大全免费视频| 午夜成年电影在线免费观看| 久久久久久人人人人人| 久久久精品欧美日韩精品| 女人被狂操c到高潮| 91在线观看av| 人人妻人人澡欧美一区二区| 制服丝袜大香蕉在线| 国内久久婷婷六月综合欲色啪| 757午夜福利合集在线观看| 国内揄拍国产精品人妻在线| 99精品久久久久人妻精品| 女人爽到高潮嗷嗷叫在线视频| 1024香蕉在线观看| 国产成人aa在线观看| 不卡av一区二区三区| 亚洲成人国产一区在线观看| 99久久国产精品久久久| 成人国产综合亚洲| 中文字幕人妻丝袜一区二区| 精品一区二区三区四区五区乱码| 成年版毛片免费区| 视频区欧美日本亚洲| √禁漫天堂资源中文www| 久久久久久人人人人人| 在线观看午夜福利视频| 女人爽到高潮嗷嗷叫在线视频| 久久中文看片网| 成人国语在线视频| 变态另类成人亚洲欧美熟女| 亚洲熟妇中文字幕五十中出| e午夜精品久久久久久久| 免费av毛片视频| 天天添夜夜摸| 99久久精品国产亚洲精品| 特大巨黑吊av在线直播| 亚洲一区高清亚洲精品| 亚洲av中文字字幕乱码综合| 欧美日韩精品网址| 草草在线视频免费看| 制服诱惑二区| 国产精品 欧美亚洲| 韩国av一区二区三区四区| 男人舔女人的私密视频| 国产成年人精品一区二区| 亚洲人与动物交配视频| www日本在线高清视频| 久久久久久久久久黄片| 99久久国产精品久久久| 又紧又爽又黄一区二区| a级毛片a级免费在线| 法律面前人人平等表现在哪些方面| 一进一出抽搐gif免费好疼| 香蕉丝袜av| 亚洲天堂国产精品一区在线| 国产精品影院久久| 俺也久久电影网| 91九色精品人成在线观看| 宅男免费午夜| 欧美中文日本在线观看视频| 变态另类成人亚洲欧美熟女| 精品国产乱码久久久久久男人| 国产aⅴ精品一区二区三区波| 精品人妻1区二区| 亚洲五月天丁香| 免费在线观看日本一区| 亚洲欧美日韩无卡精品| 人成视频在线观看免费观看| av福利片在线| 一卡2卡三卡四卡精品乱码亚洲| 亚洲国产日韩欧美精品在线观看 | 国产欧美日韩精品亚洲av| av超薄肉色丝袜交足视频| 天堂影院成人在线观看| 欧美精品亚洲一区二区| 深夜精品福利| 欧美中文日本在线观看视频| 麻豆久久精品国产亚洲av| 最近最新中文字幕大全免费视频| 欧美最黄视频在线播放免费| 国产又色又爽无遮挡免费看| 午夜激情福利司机影院| 亚洲 欧美 日韩 在线 免费| 搡老妇女老女人老熟妇| 国产激情欧美一区二区| 欧美黑人精品巨大| 国产精品亚洲av一区麻豆| 12—13女人毛片做爰片一| 国产精品久久视频播放| 亚洲精品美女久久av网站| 黑人欧美特级aaaaaa片| 18禁国产床啪视频网站| √禁漫天堂资源中文www| 中文字幕人成人乱码亚洲影| 桃色一区二区三区在线观看| 亚洲成人久久性| 一边摸一边抽搐一进一小说| 人人妻人人看人人澡| 久久久国产欧美日韩av| 久久精品成人免费网站| 成人欧美大片| 欧美+亚洲+日韩+国产| 桃红色精品国产亚洲av| 成年版毛片免费区| 天天添夜夜摸| 国产成人av激情在线播放| 国产免费av片在线观看野外av| 99久久精品国产亚洲精品| 97碰自拍视频| 非洲黑人性xxxx精品又粗又长| 每晚都被弄得嗷嗷叫到高潮| 给我免费播放毛片高清在线观看| 在线观看www视频免费| 18禁裸乳无遮挡免费网站照片| 老熟妇乱子伦视频在线观看| 色播亚洲综合网| 国语自产精品视频在线第100页| а√天堂www在线а√下载| 一本大道久久a久久精品| 久久中文字幕一级| 国产亚洲精品一区二区www| 精品久久久久久久毛片微露脸| 99国产精品99久久久久| 欧美日韩中文字幕国产精品一区二区三区| 免费在线观看日本一区| 久久香蕉国产精品| 久久 成人 亚洲| 亚洲av日韩精品久久久久久密| 久久久久久久久中文| 九九热线精品视视频播放| 99国产精品99久久久久| 亚洲人成77777在线视频| 久久 成人 亚洲| 国产私拍福利视频在线观看| 国产97色在线日韩免费| 成人av一区二区三区在线看| 中国美女看黄片| 婷婷精品国产亚洲av| 国产精品精品国产色婷婷| 怎么达到女性高潮| 久久久久久国产a免费观看| 欧美大码av| 两个人免费观看高清视频| 色综合欧美亚洲国产小说| 久久国产乱子伦精品免费另类| 欧美3d第一页| 国产一区二区在线观看日韩 | 老汉色∧v一级毛片| 后天国语完整版免费观看| 国产爱豆传媒在线观看 | 久久欧美精品欧美久久欧美| 国产视频内射| 少妇人妻一区二区三区视频| 欧美中文日本在线观看视频| 日韩 欧美 亚洲 中文字幕| 亚洲精品国产一区二区精华液| 精品国产美女av久久久久小说| 国产精品一区二区免费欧美| 床上黄色一级片| 国产亚洲精品av在线| 免费观看人在逋| 色老头精品视频在线观看| 18美女黄网站色大片免费观看| 亚洲 欧美 日韩 在线 免费| 麻豆成人午夜福利视频| 国内少妇人妻偷人精品xxx网站 | 亚洲欧美日韩高清专用| 91字幕亚洲| 亚洲人成电影免费在线| 999精品在线视频| 1024手机看黄色片| 亚洲一区中文字幕在线| 狠狠狠狠99中文字幕| 国内精品一区二区在线观看| videosex国产| 国产午夜精品论理片| 最近最新中文字幕大全免费视频| 亚洲专区国产一区二区| 啪啪无遮挡十八禁网站| 成年版毛片免费区| 丝袜人妻中文字幕| 中文亚洲av片在线观看爽| 禁无遮挡网站| 日本免费一区二区三区高清不卡| 亚洲人成伊人成综合网2020| 丁香欧美五月| 亚洲国产精品久久男人天堂| 深夜精品福利| 日韩欧美在线乱码| 色播亚洲综合网| 精品一区二区三区视频在线观看免费| 国产成人aa在线观看| 亚洲成人精品中文字幕电影| 亚洲avbb在线观看| 午夜免费观看网址| 中文字幕久久专区| 亚洲熟妇熟女久久| 男女那种视频在线观看| 黄片小视频在线播放| 国产成人啪精品午夜网站| 亚洲激情在线av| 亚洲第一电影网av| 美女高潮喷水抽搐中文字幕| 久久人妻av系列| 女生性感内裤真人,穿戴方法视频|